1.A Case of Ovarian Hyperstimulation Syndrome Associated Spontaneous Pregnancy without Ovulation Induction.
Ki Young PAENG ; So Young KIM ; Chul Gu YOON ; Min Joung KIM ; Jin Woo LEE ; Dou Kang KIM
Korean Journal of Obstetrics and Gynecology 2003;46(2):492-496
The ovarian hyperstimulation syndrome (OHSS) is a rare but serious complication of ovulation induction therapy with gonadotropin. The pathogenesis of OHSS is unclear, but the proposed mechanisms are the production of vasoactive substances that increase local capillary permeability resulting in shifting of fluid from the intravascular space to the third space. The clinical manifestations varies from ascites, hypovolemia, oliguria, hemoconcentration, thromboembolism, and even death. We have experienced a case of severe OHSS with severe ascites, pleural effusion and bilateral enlarged ovaries associated with spontaneous pregnancy without any ovarian stimulation for ovulation induction.
Ascites
;
Capillary Permeability
;
Female
;
Gonadotropins
;
Hypovolemia
;
Oliguria
;
Ovarian Hyperstimulation Syndrome*
;
Ovary
;
Ovulation Induction*
;
Ovulation*
;
Pleural Effusion
;
Pregnancy*
;
Thromboembolism
2.A Case of Leiomyoma in Vaginal Orifice.
Hyung Gun LEE ; Byoung Dae YOO ; Jin Woong SHIN ; Duck Yeong RO ; Dou Kang KIM ; Soo Pyung KIM
Korean Journal of Obstetrics and Gynecology 1997;40(6):1291-1293
Leiomyomas of the vagina are rare benign solid tumors. A leiomyoma arises frommuscle in the round ligament and appears as a firm movable tumor deep in the substanceof the labium majus, but minority of these tumors occur in vaginal wall. A case of a 39year old woman with leiomyoma of the vaginal orifice was reported with a brief review ofliterature.
Female
;
Humans
;
Leiomyoma*
;
Round Ligament of Uterus
;
Vagina
3.Complications of gynecologic laparoscopy.
Eun Kyung PARK ; Ok Kyoung KIM ; Keun Young CHEON ; Woo Mi SIN ; Dou Kang KIM
Korean Journal of Obstetrics and Gynecology 2006;49(7):1540-1546
OBJECTIVE: to describe our experience and examine the frequency of gynecologic laparoscopy complication performed in a secondary care hospital. METHODS: We retrospectively studied 262 patients were treated by gynecologic laparoscopy (mean age 43 yrs). Period of study were from March 2003 through March 2005 in one teaching hospital. Data were analyzed using SPSS for windows software. Frequency and descriptive statistics were calculated. RESULTS: The overall number of complication in 262 laparoscopies was 16 (6.1%). 5 ureter injuries, 3 stump disruption, 2 troca site hematoma, 1 bladder injury, 1 small bowel injury, 1 post operative bowel obstruction, 1 leg neuropathy, 1 leg weakness, 1 massive bleeding. The complication rates were analysed by type of surgery. We evaluated correlation with variable factors. Our complication rates were higher to those reported in the literature and were significantly different by type of surgery. Complications were related to variable factors of blood transfusion and anesthetic time. CONCLUSION: The complication rate occurred at higher rates in our institution. All patients complications developed were treated and none sustained long-term morbidity. However, operative laparoscopy should be performed carefully. Early recognition of injuries, preferably intraoperatively, with immediate appropriate treatment is crucial. It is also important to be alert to early manifestations of complications in the postoperative observation period.
Blood Transfusion
;
Hematoma
;
Hemorrhage
;
Hospitals, Teaching
;
Humans
;
Laparoscopy*
;
Leg
;
Retrospective Studies
;
Secondary Care
;
Ureter
;
Urinary Bladder
4.A Case of Burkitt`s Lymphoma of the Ovary.
Hee Joong LEE ; Sang Ha HAN ; Byoung Dae YOO ; Duck Yeoung RO ; Dou Kang KIM ; Soo Pyung KIM
Korean Journal of Obstetrics and Gynecology 1997;40(11):2594-2599
Malignant ovarian lymphoma is a very rare entity and has a poor prognosis. A 32-year-old woman visited Taejon St, Mary`s hospital due to abdominal discomfort and pelvic mass. Under the impression of ovarian malignancy, total abdominal hysterectomy with bilateral salpingpo-ophorectomy, lymph node biopsy was done. Histopathologic and immunohistochemical study demonstrated the tumor to be Burkitt`s lymphoma of the ovary with involvement of the uterus, tubes, and bone marrow. Now she got one cycle of CHOP(cyclophosphamide, adriamycin, vincristine, prednisolone) chemotherapy and then follow up via OPD. We have reported a case of Burkitt`s lymphoma of the ovary with a brief review of literature.
Adult
;
Biopsy
;
Bone Marrow
;
Daejeon
;
Doxorubicin
;
Drug Therapy
;
Female
;
Follow-Up Studies
;
Humans
;
Hysterectomy
;
Lymph Nodes
;
Lymphoma*
;
Ovary*
;
Prognosis
;
Uterus
;
Vincristine
5.Development of Trans Attack Anticancer Gene Vaccine Interact in HPV Oncoprotein Expression Inhibition.
Hee Joong LEE ; Sung Ha LEE ; Hyun Jung KIM ; Jae Hoon KIM ; Young Ok LEW ; Jin Ok LEE ; Young Wan KIM ; Woong Shick AHN ; Chong Kook KIM ; Jun Mo LEE ; Dae Hoon KIM ; Sung Eun NAMKOONG ; Kim Dou KANG
Korean Journal of Obstetrics and Gynecology 2004;47(2):258-263
OBJECTIVE: Adeno-associated virus Rep 78 protein is known to inhibit the promoter site of several onco-genes and viral gene, including the human papillomavirus type 16 E6 transforming genes. In this study, we investigated AAV Rep 78 mediated inhibition of HPV 16 E6 promotor activity. METHODS: pcDNA3.1/V5/His-Topo vector, cloned by AAV mediated Rep 78, is transfected into cervical cancer cell line (Caski). After that, we confirmed HPV16 derived E6 expression and cell growth inhibition. RESULTS: Transfection rate of Rep78 GFP-vector, approximately from 30 to 60 per-cent, is highly expressed at first day. But E6 expression is lower at this day. The growth of CaSki and HeLa cervical cancer cell lines was inhibited by Rep78 (p<0.05). But, the other cervical cancer cells were unaffected by Rep78 transfection. CONCLUSION: In spite of the high Rep78 transfection efficiency and expression rate, we could not show the cervical cancer cell growth inhibition. In our data, long term expression of Rep78 strategy is needed for cervical carcinoma gene therapy using adeno-associated virus vector.
Cell Line
;
Clone Cells
;
Dependovirus
;
Genes, Viral
;
Genetic Therapy
;
Human papillomavirus 16
;
Humans
;
Oncogenes
;
Transfection
;
Uterine Cervical Neoplasms
6.Induction of Anti-tumor Immunity by Vaccination with E7 of HPV16 and IL-12.
Eun Kyung PARK ; Tae Young JIN ; Chul Gu YOON ; Mi Nah CHOI ; Seung Won HUH ; Su Mi BAE ; Young Wan KIM ; Joo Hee YOON ; Woong Shick AHN ; Chong Kook KIM ; Jun Mo LEE ; Sung Eun NAMKOONG ; Kim Dou KANG
Korean Journal of Obstetrics and Gynecology 2003;46(12):2373-2379
OBJECTIVE: Interleukin-12 is well known to induce cellular immune response materials and suppress the tumor growth. HPV infection has significant roles in cervical carcinogenesis, and HPV oncoprotein E6 and E7 are important roles in formation and maintenance of cervical cancer. E7 specific immune response was detected in cervical cancer patients, and this shows that E7 protein would be important in potential immunetherapy in cervical cancer. This study is aimed to investigate antitumor effect and E7 immune response by injection of adenovirus IL-12 and E7 in cervical cancer animal model. METHODS: In the cervical cancer animal model using C57BL/6 mice and HPV16 E7 immortalized hosts, 5 X 10(8) pfu/100 ul of PBS, AdLacZ, AdE7 and AdIL-12 were injected into the tumor mass when the tumor sized is increased to 7-8 mm. After the injection, the tumor size was caliperated every 2-3 days, and pathologic and blood studies were done on day 1, 3, 5, 7, 11, 12, and 21 days. The expression level of IL-12 and INF- and E7 specific immune response were measured by ELISA. RESULTS: After the injection of AdIL-12 into the tumor mass, 45% of tumor growth suppression was noted in comparison with control group. In the cases of combination injections of AdIL-12 and AdE7, 80% growth suppression was observed, and complete regression was shown in 40% of the study group. After injection of AdIL-12, the expression of IL-12 in the tumor mass was 9 time higher than that of control group, and 6 times higher in blood sample in comparison with control group. In the group with combined AdIL-12 and AdE7, the highest expression of INF- was noted in comparison with single injection of AdIL-12 or control group. IgGI and IgG2b isotype expression level increased 2.5 times and 2.2 times respectively 3 weeks after adenovirus injection. CONCLUSION: In cervical cancer animal model, IL-12 and E7 application using Adenovirus vector is significant antitumor effect and this demonstrates the potential immunotherapy in near future.
Adenoviridae
;
Animals
;
Carcinogenesis
;
Enzyme-Linked Immunosorbent Assay
;
Humans
;
Immunity, Cellular
;
Immunoglobulin G
;
Immunotherapy
;
Interleukin-12*
;
Mice
;
Models, Animal
;
Uterine Cervical Neoplasms
;
Vaccination*